- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02861508
Impact of Immediate Point-of-Care Ultrasound on Patients With Cardiopulmonary Symptoms in the Emergency Department
27 februari 2020 bijgewerkt door: Yale University
The purpose of the proposed research is to examine whether incorporating point-of-care ultrasound (POCUS) early in diagnostic work-up of cardiopulmonary complaints will affect diagnosis, time to condition-specific intervention, and ultimately patient outcomes compared to usual care.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Studietype
Ingrijpend
Inschrijving (Werkelijk)
170
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Connecticut
-
New Haven, Connecticut, Verenigde Staten, 06510
- Yale New Haven Hospital
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Chief complaint of chest pain, dyspnea (either sudden onset or increased severity of chronic dyspnea), syncope, or hypotension (systolic blood pressure <100 or shock index [heart rate divided by systolic blood pressure] >1)
Exclusion Criteria:
- <18 years old
- Prisoner or ward of the state
- Trauma
- High acuity requiring treatment in resuscitation room
- Obvious cause of symptoms (e.g. acute GI bleed causing hypotension)
- Any form of "do not resuscitate" (DNR) order
- Roomed in hall of emergency department (location not amenable to ultrasound protocol)
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Usual care
Usual care as determined by treating team.
Ultrasound may still be part of the workup per the treating team's discretion.
|
|
|
Experimenteel: Early POCUS
Point-of-care ultrasound protocol will involve cardiac views (for pericardial effusion, left ventricular function, left and right ventricular equality, aortic root dilation, and inferior vena cava status), lung views (for pneumothorax, signs of alveolar interstitial syndrome), abdominal views for free fluid, and a view of the abdominal aorta for aneurysm.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Time to appropriate intervention
Tijdsspanne: Within 30 days of presentation
|
Based on final diagnosis as determined by final review of the patient's overall visit in the medical record, it will be determined what the appropriate intervention(s) that the patient should have received.
Subsequently, the amount of time that elapsed (minutes) between time the patient was roomed in the emergency department (ED) and time to when they received the intervention will be collected.
All these time points are readily available in the electronic medical record in the patient care timeline.
This outcome will help determine whether early POCUS affects how quickly patients receive appropriate intervention.
|
Within 30 days of presentation
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Diagnostic accuracy
Tijdsspanne: Within 30 days of presentation
|
The treating team in the ED will be asked for their diagnostic impression of the patient's chief complaint at several points during the patient's time in the ED.
These points will be (1) after the primary provider's initial assessment, (2) at time of disposition, and (3) if they are in the early POCUS group, after the POCUS findings are relayed to them.
They will select their single most likely diagnosis each time, which will be compared against a final diagnosis as determined by final review of the patient's overall visit in the medical record (as this study's gold standard for diagnosis).
This outcome will examine how often (percentage-wise) the treating team's diagnosis matches the final diagnosis as well as if early POCUS has any impact on helping physicians reach the correct diagnosis.
|
Within 30 days of presentation
|
|
Diagnostic certainty
Tijdsspanne: Within 2 days of presentation
|
Similar to the outcome of diagnostic accuracy, the treating team in the ED will concomitantly be asked how certain they feel about their diagnosis on a five-point scale.
The presence of any changes in certainty (i.e.
proportion of patients for whom certainty changed) as well as how much change (e.g.
increased certainty by 2 points) will be assessed.
This outcome will determine if early POCUS affects physicians' certainty of diagnosis.
|
Within 2 days of presentation
|
|
Time to disposition
Tijdsspanne: Within 2 days of presentation
|
This will be measured as amount of time (in minutes) that elapse between the time patient is roomed in the ED to time the treating team determines patient disposition.
These timestamps are available in the medical record under the patient care timeline.
This outcome will examine if early POCUS affects the time it takes for the treatment team to achieve a disposition plan for the patient.
|
Within 2 days of presentation
|
|
Total length of stay
Tijdsspanne: Within 30 days of presentation
|
This will be measured as time (in days) between the patient's date of presentation and date of discharge.
This outcome will examine if early POCUS affects the amount of time that patients stay in the hospital.
|
Within 30 days of presentation
|
|
30-day in-hospital mortality
Tijdsspanne: Within 30 days of presentation
|
Patients will be followed in their medical record for up to 30 days after their initial presentation to assess for in-hospital mortality rate.
This outcome will examine if early POCUS leads to any significant difference in patient mortality rate compared to usual care.
|
Within 30 days of presentation
|
|
Duration of POCUS
Tijdsspanne: Within 2 days of presentation
|
For the early POCUS group, this will be measured as the amount of time (in minutes) between the time the ultrasound is started and the time the last image is captured.
All images/video clips acquired by the ultrasound machine have a timestamp.
A blank image will be captured at the start of the exam for the initial timestamp.
This outcome will examine how time-consuming our POCUS exam is and provides a sense of how disruptive the introduction of POCUS might be if it were implemented routinely.
|
Within 2 days of presentation
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Return visits with missed diagnosis
Tijdsspanne: Within 30 days of presentation
|
The patient's medical record will be followed for 30 days after initial presentation for the presence of any repeat visits with the healthcare system for a similar chief complaint.
If so, that repeat visit will be reviewed for the presence of a different diagnosis than that established at the original visit, which would suggest that the correct diagnosis had been missed at that time.
It will then be determined what the percentage of patients is with such visits out of all patients in the study.
This outcome will examine if POCUS helps with picking up diagnoses that might be missed otherwise.
|
Within 30 days of presentation
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Christopher Moore, MD, Yale University
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
1 juli 2016
Primaire voltooiing (Werkelijk)
30 juni 2018
Studie voltooiing (Werkelijk)
30 juni 2018
Studieregistratiedata
Eerst ingediend
5 augustus 2016
Eerst ingediend dat voldeed aan de QC-criteria
5 augustus 2016
Eerst geplaatst (Schatting)
10 augustus 2016
Updates van studierecords
Laatste update geplaatst (Werkelijk)
28 februari 2020
Laatste update ingediend die voldeed aan QC-criteria
27 februari 2020
Laatst geverifieerd
1 februari 2020
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Pathologische processen
- Hart-en vaatziekten
- Vaatziekten
- Ziekten van het zenuwstelsel
- Ziekten van de luchtwegen
- Ademhalingsstoornissen
- Pijn
- Neurologische manifestaties
- Neurologische gedragsmanifestaties
- Ziekte attributen
- Tekenen en symptomen, ademhaling
- Bewusteloosheid
- Bewustzijnsstoornissen
- Spoedgevallen
- Pijn op de borst
- Hypotensie
- Syncope
- Dyspneu
Andere studie-ID-nummers
- 1605017729
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Nee
Beschrijving IPD-plan
No specific plans for now but would be open to sharing anonymized data.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .